Founded in 2021, Z7 Biotech is at the forefront of pioneering early-stage drug discovery. Our mission is to develop and provide our clients with cutting-edge pharmacological and biophysical technologies that revolutionise the way we understand and approach complex biological targets. Our team is composed of world-class experts who bring a wealth of knowledge and experience to every project.
We are the “go-to” Contract Research Organization (CRO) for ‘cold start’ drug discovery programs in scenarios devoid of existing hits or tool compounds. Partnering with pharma and academia to collaboratively solve early discovery challenges. We specialize in innovative screening assays that are not just effective, but also tailored to meet the unique needs of each drug discovery endeavour.
For collaborations or inquiries, reach out to us at info@z7bio.com.
OUR TEAM
MEET THE TEAM
PROF. DMITRY VEPRINTSEV
Founder
25+ years international experience in
structural and biophysical pharmacology
DR OWEN UNDERWOOD
Senior Scientist
5+ years experience in drug discovery
in industry and academia
DR DAVID SYKES
Founder
25+ years experience in drug discovery
in industry and academia
GRACE BAMFORD
Research Scientist
2+ years experience in drug discovery
in industry and academia
DUNCAN CLARK
Founder
25+ years international investment
banking and risk management
RAVINDER BHARDWAJ
PhD Student
Z7 Biotech sponsored PhD student, funded by the MRC under the MRC-AIM Doctoral Training Partnership programme